Nocturnal is a prime player in the manufacturing industry, founded in 2011 and headquartered in the United States. Their slogan "Startup-friendly medical device development" truly encapsulates their mission, which is to expedite the commercialization journey for early stage medical device companies focusing on class II and class III, implantable, and lifesaving devices. Their unique engagement model aims to mitigate technology, regulatory, and financial risks for medical device entrepreneurs. Nocturnal boasts of hard-to-find expertise in the development of complex class II and III implantable and lifesaving devices, making them a go-to partner for development projects. Furthermore, their startup-friendly business model and result-based development pricing provide budget predictability, which is highly appreciated by their clients. Additionally, their boutique approach, with top experts being hands-on from start to finish, garners strong client appreciation. For the latest updates and more information, interested parties can follow Nocturnal on their website: https://nocturnalpd.com.
There is no investment information
No recent news or press coverage available for Nocturnal.